In Alzheimer’s disease (AD), younger symptom onset is associated with accelerated disease progression and tau spreading, yet the mechanisms underlying faster disease manifestation are unknown. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.